Status:
COMPLETED
Preventing Brain Injury in Infants With Congenital Heart Disease
Lead Sponsor:
University of California, Davis
Conditions:
Cyanotic Congenital Heart Disease
Eligibility:
All Genders
Up to 2 years
Phase:
PHASE1
Brief Summary
Newborn babies with congenital heart disease often require surgery in the first month of life. The risks of brain damage from congenital heart disease and from the various corrective surgeries are hig...
Detailed Description
Infants with cyanotic congenital heart disease undergoing surgery in the neonatal period have a high rate of brain injury resulting in seizures, stroke, cerebral palsy, and neurodevelopmental delays. ...
Eligibility Criteria
Inclusion
- Age less than 2 months
- Cyanotic congenital heart disease requiring surgery
Exclusion
- Genetic syndromes with high risk of neurodevelopmental delay
- Gestational age less than 35 weeks at birth
- Multiple organ failure or multiple organ anomalies
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2017
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01426542
Start Date
March 1 2011
End Date
July 28 2017
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Children's Hospital
Sacramento, California, United States, 95817